Matzim La Tablet, Extended Release
Product Images NDC 52544-692

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Matzim La (NDC 52544-692). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Matzim LA 180 mg extended-release oral tablets packaging label. The label shows the product name, strength, dosage form, and route of administration. Manufactured by Actavis Pharma, Inc.*

FDA Label Image

Image 10

Matzim LA 240 mg extended release oral tablets packaging label by Actavis Pharma, Inc. The label shows the brand name Matzim LA prominently along with the active ingredient diltiazem hydrochloride and the strength of 240 mg per tablet. The label also includes basic regulatory and manufacturing information.*

FDA Label Image

Image 11

Matzim LA 300 mg extended release oral tablets packaging label. The label displays the brand and generic name Diltiazem Hydrochloride, strength of 300 mg, and indicates the tablet is extended release. The manufacturer is Actavis Pharma, Inc.*

FDA Label Image

Image 12

Label for Matzim LA 180 mg Extended-Release Tablets containing Diltiazem Hydrochloride. The label indicates once-a-day dosage, packaging of 30 tablets, and is for prescription use only. Manufactured by Actavis Pharma, Inc., with storage instructions and a barcode on the right side.*

FDA Label Image

Image 13

Matzim LA 240 mg extended-release oral tablets by Actavis Pharma, Inc. The label states the active ingredient as Diltiazem Hydrochloride 240 mg, packaged as 30 tablets for prescription use. It includes dosage instructions to take once daily and storage conditions at 20° to 25°C. The label features both manufacturer and distributor addresses and a barcode.*

FDA Label Image

Image 14

Matzim LA 300 mg extended-release oral tablets label showing brand and generic names, dosage form, strength, and once-a-day dosage instruction. The label includes a 30-tablet count, manufacturer Actavis Pharma, Inc., and storage and warning instructions. It features the NDC 52544-693-30 and barcode on a white and purple background.*

FDA Label Image

Image 15

Matzim LA 360 mg extended-release oral tablets label showing diltiazem hydrochloride as the active ingredient. The label indicates a once-a-day dosage, 30 tablets per container, and is marked Rx only. It includes storage instructions, manufacturer Actavis Pharma, Inc., and distributor information, with a barcode on the right side.*

FDA Label Image

Image 16

Matzim LA 420 mg extended-release oral tablets packaging label featuring diltiazem hydrochloride as the active ingredient. The label indicates a 30-tablet count with once-a-day dosage, manufactured by Actavis Pharma, Inc., and includes storage instructions and a barcode.*

FDA Label Image

Image 2

Matzim LA 180 mg extended release oral tablet packaging label. The label includes the proprietary name Matzim LA, generic name Diltiazem Hydrochloride, 180 mg strength, and the labeler Actavis Pharma, Inc. The tablet count and other specific packaging details are not visible.*

FDA Label Image

Image 3

Matzim LA 180 mg extended release tablets packaging label shows the brand and generic name, Diltiazem Hydrochloride, manufactured by Actavis Pharma, Inc. The label includes dosage strength 180 mg and indicates the extended release oral tablet form.*

FDA Label Image

Image 4

Matzim LA 240 mg extended-release tablets in an oral dosage form are shown in a white and green blister card with five tablets. The label displays the product name, strength, dosage form, and the manufacturer Actavis Pharma, Inc.*

FDA Label Image

Image 5

The image shows a carton for Matzim LA 180 mg extended release tablets. The front panel displays the proprietary name Matzim LA, the active ingredient Diltiazem Hydrochloride, and the strength of 180 mg. The dosage form is oral extended release tablets. The labeler is Actavis Pharma, Inc. The package contains 30 tablets with NDC 59:2247.*

FDA Label Image

Image 6

Chemical structure diagram of Diltiazem Hydrochloride showing its molecular framework with labeled atoms and bonds, including a hydrochloride moiety.*

FDA Label Image

Image 7

Matzim LA 180 mg extended-release oral tablets packaging label. The label displays the brand name Matzim LA, the generic name Diltiazem Hydrochloride, and the strength of 180 mg. It is identified as a human prescription drug manufactured by Actavis Pharma, Inc.*

FDA Label Image

Image 8

Matzim LA 240 mg extended release oral tablets in a green and white blister pack labeled with the brand and generic name Diltiazem Hydrochloride, manufactured by Actavis Pharma, Inc.*

FDA Label Image

Image 9

Matzim LA 180 mg extended-release oral tablets packaging. The label shows the proprietary name Matzim LA and active ingredient Diltiazem Hydrochloride. The strength displayed is 180 mg. The product is labeled as a human prescription drug from Actavis Pharma, Inc. The label includes quantity and dosage form details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.